Maelle Duffey
Geneve, GE 1202, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
In vitro activity of flomoxef, fosfomycin and amikacin versus a global panel of third-generation cephalosporin-resistant Enterobacterales and prediction of their ability in pairwise combinations to work as carbapenem-sparing regimens.
Journal: Journal of global antimicrobial resistance
Published: January 19, 2026
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum.
Journal: Nature communications
Published: March 26, 2025
An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs.
Journal: Nature communications
Published: December 04, 2024
Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates.
Journal: Antimicrobial agents and chemotherapy
Published: August 13, 2024
Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.
Journal: ACS infectious diseases
Published: April 25, 2024
Combating antimicrobial resistance in malaria, HIV and tuberculosis.
Journal: Nature reviews. Drug discovery
Published: March 15, 2024
Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections.
Journal: Nature reviews. Drug discovery
Published: August 15, 2023
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
Journal: Microbiology spectrum
Published: May 09, 2023
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 20, 2022
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.
Journal: Cell chemical biology
Published: November 15, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362.
Journal: Journal of medicinal chemistry
Published: October 10, 2022
Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors.
Journal: Antimicrobial agents and chemotherapy
Published: September 12, 2022
Last Updated: 09/26/2026